Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 16 Mar 2004 |
| Genmab, notice convening annual general meeting the 1. April 2004 | 10 Mar 2004 |
| Genmab, Capital Increase as a Result of Employees' Warrant Exercise | 9 Mar 2004 |
| Genmab, current statement of shareholdings | 9 Mar 2004 |
| Genmab, articles of association from the March 9, 2004 | 9 Mar 2004 |